Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 24 symbols : Jnj save search
As Cases Decline, Scientists Work to Develop Anti-COVID-19 Pill for Seasonal ...
Published: 2021-05-24 (Crawled : 00:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.04%
H: 0.26%
C: -0.2%
covid anti-covid covid-19
MicroGenDX Announces OrthoKEY® Infection Diagnosis and Management for Periprosthetic Joint Infection
Published: 2021-05-24 (Crawled : 23:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.07%
H: 0.21%
C: -0.35%
injection diagnostic infections
Johnson & Johnson to Host Live ESG Investor Update Webcast
Published: 2021-05-24 (Crawled : 21:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.07%
H: 0.21%
C: -0.35%
Global Cough Syrup Market (2020 to 2027) - by Product Type, Age Group, Distribution Channel and Region
Published: 2021-05-24 (Crawled : 20:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.07%
H: 0.21%
C: -0.35%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.47%
H: 0.03%
C: -0.49%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 0.61%
H: 1.05%
C: 0.34%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: -0.63%
distribution
Insights on the Oncology/Cancer Drugs Global Market to 2027 - Opportunity Analysis and Industry Forecasts
Published: 2021-05-24 (Crawled : 20:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.07%
H: 0.21%
C: -0.35%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.07%
H: 0.33%
C: -0.86%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.05%
H: 0.03%
C: -1.22%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.24%
H: 0.05%
C: -0.73%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.44%
H: 0.44%
C: -1.89%
cancer drug
Neurovascular Devices Market worth $3.8 billion by 2026 - Exclusive Report by MarketsandMarkets™
Published: 2021-05-24 (Crawled : 16:00) - prnewswire.com
SYK | $334.91 2.21% -4.72% 1.4M
|
Health Technology
|
| O: 0.58%
H: 0.55%
C: 0.0%
PEN F | $205.7 1.33% 0.0% 390K
|
Health Technology
|
| O: 0.5%
H: 0.04%
C: -3.74%
MDT | $81.29 0.89% 0.0% 5.2M
|
Health Technology
|
| O: 0.63%
H: 0.45%
C: 0.01%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.04%
H: 0.26%
C: -0.2%
device
Johnson & Johnson's Scott White Elected To CEO Roundtable On Cancer Board Of Directors
Published: 2021-05-24 (Crawled : 16:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.04%
H: 0.26%
C: -0.2%
cancer ceo leo
As Cases Decline, Scientists Work to Develop Anti-COVID-19 Pill for Seasonal Variants
Published: 2021-05-24 (Crawled : 16:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.04%
H: 0.26%
C: -0.2%
covid anti-covid covid-19
Clinical Catch-Up: May 17-21
Published: 2021-05-24 (Crawled : 14:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.04%
H: 0.26%
C: -0.2%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.02%
H: 0.3%
C: -0.3%
Janssen's Updated Phase 1 Results for Teclistamab Suggest Deep, Durable Responses in Patients with Heavily Pretreated Multiple Myeloma
Published: 2021-05-24 (Crawled : 13:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.04%
H: 0.26%
C: -0.2%
phase 1 results phase 3 phase 2 response
Janssen Presents Updated Data on First-in-Class Talquetamab at ASCO Suggesting Deep and Durable Responses in Heavily Pretreated Patients with Multiple Myeloma
Published: 2021-05-24 (Crawled : 13:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.04%
H: 0.26%
C: -0.2%
Centene Appoints Suzy DePrizio as Chief Marketing Officer
Published: 2021-05-24 (Crawled : 12:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.04%
H: 0.26%
C: -0.2%
CNC | $75.84 0.34% 0.0% 1.7M
|
Health Services
|
| O: 0.31%
H: 0.58%
C: -0.05%
Animal Wound Care Market Size Worth $1.5 Billion By 2028 | CAGR: 6.4%: Grand View Research, Inc.
Published: 2021-05-24 (Crawled : 09:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.04%
H: 0.26%
C: -0.2%
MMM | $93.0 0.41% -0.4% 3.7M
|
Producer Manufacturing
|
| O: 0.47%
H: 0.35%
C: -0.09%
SNOA | $0.1574 4.76% 150K
|
Health Technology
|
| O: -1.07%
H: 1.75%
C: 0.81%
NEOG P | $12.3 4.41% 4.23% 2.6M
|
Health Technology
|
| O: -49.9%
H: 1.69%
C: 1.04%
wound care research
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.